Skip to main content
. 2023 Nov 24;2023:2821056. doi: 10.1155/2023/2821056

Table 2.

General pulmonary function characteristics of study population.

Total population n = 681 COPD n = 187 No COPD n = 494 p value
Weight in kg, mean (SD) 71.3 (13.6) 69.3 (13.8) 72.1 (13.4) 0.014
Height in cm, mean (SD) 159.6 (9.2) 160.3 (9.1) 159.3 (9.3) 0.185

FVC% predicted pre-B2, mean (SD) 95.1 (19.14) 90.6 (19.9) 96.7 (18.6) <0.001
FVC% predicted post-B2, mean (SD) 97.9 (18.1) 97.5 (19.8) 98 (17.5) 0.736
FEV1% predicted pre-B2, mean (SD) 87.5 (22.6) 68.8 (20.8) 94.5 (18.1) <0.001
FEV1% predicted post-B2, mean (SD) 93.4 (21.1) 77.3 (20.8) 99.3 (17.9) <0.001
FEV1/FVC pre-B2%, mean (SD) 70.8 (12.1) 57.9 (10.1) 75.5 (8.8) <0.001
FEV1/FVC post-B2%, mean (SD) 73.8 (10.6) 59.8 (8.4) 79 (5.3) <0.001

Z score FVC pre-B2, mean (SD) −0.2 (1.59) −0.6 (1.53) 0.1 (1.59) <0.001
Z score FVC post-B2, mean (SD) −0.1 (1.39) −0.1 (1.68) 0.1 (1.27) 0.664
Z score FEV1 pre-B2, mean (SD) −0.7 (1.67) −2.0 (1.56) −0.2 (1.42) <0.001
Z score FEV1 post-B2, mean (SD) −0.4 (1.5) −1.5 (1.42) 0.1 (1.28) <0.001
Z score FEV1/FVC pre-B2, mean (SD) −0.5 (1.0) −1.6 (1.05) −0.2 (0.62) <0.001
Z score FEV1/FVC post-B2, mean (SD) −0.3 (0.92) −1.4 (0.84) 0.1 (0.49) <0.001

COPD: chronic obstructive pulmonary disease, kg: kilograms, SD: standard deviation, cm: centimeters, COPD: chronic obstructive pulmonary disease, B2: beta-2-agonist, FVC: forced vital capacity, and FEV1: forced expiratory volume in the first second.